Acology Reports Upsurge in Global Sales, Projects

CORONA, Calif., March 13, 2017 (GLOBE NEWSWIRE) -- Acology Inc. (OTC:ACOL) announced today that international orders continue to rise and that North American orders have remained strong despite some ambiguity in the political landscape.

In the wake of rising international acceptance of cannabis products Acology is now benefitting from marketing efforts which began 2 years ago, anticipating that the industry would expand, first in Europe and Great Britain and then to Asia and South America. Focusing on the growing demand, distributors from more than 19 countries now sell Acology products. International sales accounted for more than 20% of Acology sales last year. Management conservatively predicts that, based on current sales levels, the percentage will rise by more than 15% this year.

Acology’s expansion from its’ current 6,000 sq. ft. to 13,000 sq. ft., detailed in its’ previous press release, continues. Its expansion into hydroponic products, which include growing systems, hydration products, nutrients and general cultivation products and services, has started to gain traction. Four and an eventual eight sales associates have been hired specifically for their network experience in hydroponic products and are starting to produce results. Awareness of the Acology brand continues to expand in markets across the globe.

The current ambiguous state of US federal policy towards  the cannabis industry seems to have been mostly ignored by states that have already legalized. Nor will it stop 10 new states that are planning state-wide votes on cannabis legalization in 2017. Revenues generated from cannabis industry sales have resulted in sharp increases in tax revenues and economic experts from a wide range of political points-of-view predict that this trend will not only continue, but is unstoppable.

For investor or sales information please visit Acology Inc. and D&C Distributors online or by phone. The company is located in their production and distribution facility at 1620 Commerce St. Corona, California, 92880.

Acology trades on the OTC under the call letters ACOL. The company’s websites are www.Acologyinc.com for the hospice and palliative care industry and www.themedtainer.com for the recreational and medical marijuana industry. Orders for Acology products can be taken online and by phone. Custom orders are especially welcome.  Please send all inquiries to info@acologyinc.com or call (844) ACOLOGY (844-226-5649). Ask for Jack Rein, National Services Director.  Acology can also be accessed through Twitter and Instagram at @Acologyinc.

This press release includes statements that are covered by the Private Securities Litigation Reform Act of 1995. Because such statements deal with future events they are subject to risks and uncertainties and actual results for fiscal year 2016 and beyond could differ materially from the company’s current expectations. Forward-looking statements are identified by such words as “anticipates”, “projects”, “expects”, “planned”, “intends” and “believes” “estimate” “targets” and other similar expressions that indicate trends and future events. It is understood that investment entails risk on the part of the investor and could result in the loss of some or all his or her investment.

Contact: Curt Fairbrother 951-640-4056